by Limnopharma | Jun 28, 2019 | Noticias
Limnopharma is the first company to find a treatment to cure Retinitis Pigmentosa (RP) and Age-Related Macular Degeneration (AMD).
by Limnopharma | Jun 25, 2019 | Noticias
The biotechnology start-up will be at Alhambra Venture 2019 Around 250 million people live with visual disabilities worldwide. Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP) are two of the diseases that cause visual impairment and blindness. They...
